Scarica l'app Stockscreener
2.26
3.42%
-0.08
Dopo l'orario di chiusura:
2.22
-0.04
-1.77%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AYTU Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.34
Aprire:
$2.33
Volume 24 ore:
43,391
Relative Volume:
0.15
Capitalizzazione di mercato:
$20.29M
Reddito:
$93.76M
Utile/perdita netta:
$-13.68M
Rapporto P/E:
-0.8593
EPS:
-2.63
Flusso di cassa netto:
$8.77M
1 W Prestazione:
-2.16%
1M Prestazione:
-14.72%
6M Prestazione:
+79.37%
1 anno Prestazione:
-5.44%
Intervallo 1D:
$2.24
$2.3875
Intervallo di 1 settimana:
$2.24
$2.43
Portata 52W:
$0.95
$2.85
Aytu Biopharma Inc Stock (AYTU) Company Profile
Nome
Aytu Biopharma Inc
Settore
Telefono
(720) 437-6580
Indirizzo
7900 E. UNION AVENUE, DENVER
Confronta AYTU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.26 | 21.10M | 93.76M | -13.68M | 8.77M | -2.63 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Iniziato | Lake Street | Buy |
| 2025-06-30 | Iniziato | Ascendiant Capital Markets | Buy |
| 2021-03-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-05-29 | Iniziato | H.C. Wainwright | Buy |
Aytu Biopharma Inc Borsa (AYTU) Ultime notizie
Can Aytu BioPharma Inc. benefit from deglobalizationJuly 2025 Market Mood & Real-Time Market Trend Scan - khodrobank.com
Key metrics from Aytu BioPharma Inc.’s quarterly dataPortfolio Performance Summary & Real-Time Volume Spike Alerts - Newser
Will Aytu BioPharma Inc. see short term momentumTrade Risk Assessment & Daily Volume Surge Trade Alerts - Newser
Analyzing Aytu BioPharma Inc. with risk reward ratio chartsMarket Risk Analysis & Weekly High Potential Alerts - Newser
Will Aytu BioPharma Inc. continue its uptrendPortfolio Return Summary & Real-Time Buy Signal Alerts - Newser
Is Aytu BioPharma Inc. stock entering bullish territoryJuly 2025 Opening Moves & Capital Protection Trade Alerts - Newser
What data driven models say about Aytu BioPharma Inc.’s futureJuly 2025 Momentum & Weekly Breakout Stock Alerts - Newser
Is Aytu BioPharma Inc. forming a bottoming baseEarnings Beat & Growth Focused Stock Reports - Newser
Combining price and volume data for Aytu BioPharma Inc.2025 Earnings Impact & Safe Capital Allocation Plans - Newser
Certain Stock Options of Aytu BioPharma, Inc. are subject to a Lock-Up Agreement Ending on 4-SEP-2025. - MarketScreener
Live market analysis of Aytu BioPharma Inc.July 2025 Recap & Growth Focused Stock Reports - Newser
Risk vs reward if holding onto Aytu BioPharma Inc.Earnings Performance Report & AI Driven Stock Movement Reports - Newser
Will Aytu BioPharma Inc. rebound enough to break evenJuly 2025 Market Mood & Reliable Entry Point Alerts - Newser
Fed Meeting: What hedge funds are buying Aytu BioPharma Inc.2025 Valuation Update & Scalable Portfolio Growth Ideas - khodrobank.com
Custom watchlist performance reports with Aytu BioPharma Inc.Market Weekly Review & Verified Entry Point Signals - Newser
What machine learning models say about Aytu BioPharma Inc.July 2025 Final Week & High Accuracy Trade Signal Alerts - Newser
Will Aytu BioPharma Inc. benefit from macro trendsWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - Newser
What hedge funds are buying Aytu BioPharma Inc.Weekly Risk Report & Daily Chart Pattern Signal Reports - khodrobank.com
Is Aytu BioPharma Inc. stock a top performer YTD2025 Trading Recap & Fast Moving Stock Watchlists - khodrobank.com
Is Aytu BioPharma Inc. a defensive stockGlobal Markets & Weekly High Return Stock Forecasts - khodrobank.com
Should you avoid Aytu BioPharma Inc. stock right nowWeekly Trading Summary & Fast Moving Stock Watchlists - khodrobank.com
How to manage a losing position in Aytu BioPharma Inc.July 2025 Decliners & Low Drawdown Investment Strategies - Newser
Is Aytu BioPharma Inc. trending in predictive chart modelsMarket Sentiment Report & Daily Profit Focused Screening - Newser
What is Aytu BioPharma Inc.’s valuation compared to sector2025 Technical Patterns & Smart Money Movement Tracker - خودرو بانک
VIX Spike: Is Aytu BioPharma Inc. still a buy after recent gains2025 Momentum Check & Safe Entry Trade Reports - khodrobank.com
Is Aytu BioPharma Inc. still a buy after recent gainsQuarterly Market Review & Growth Focused Stock Reports - khodrobank.com
Detecting price anomalies in Aytu BioPharma Inc. with AIVolume Spike & Weekly Chart Analysis and Trade Guides - Newser
Why Aytu BioPharma Inc. is moving todayOil Prices & Daily Momentum Trading Reports - Newser
Fibonacci Levels Suggest Recovery for Aytu BioPharma Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Will earnings trigger a reversal in Aytu BioPharma Inc.July 2025 Update & Free Long-Term Investment Growth Plans - Newser
Can trapped investors hope for a rebound in Aytu BioPharma Inc.July 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
Risk adjusted return profile for Aytu BioPharma Inc. analyzedJuly 2025 EndofMonth & Capital Protection Trading Alerts - Newser
Aytu Biopharma Inc Azioni (AYTU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Aytu Biopharma Inc Azioni (AYTU) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Disbrow Joshua R. | Chief Executive Officer |
Jun 09 '25 |
Buy |
1.50 |
66,666 |
99,999 |
153,257 |
| Disbrow Joshua R. | Chief Executive Officer |
Feb 28 '25 |
Buy |
1.30 |
15,000 |
19,500 |
86,591 |
3.60%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):